大鼠实验性脾虚证胃粘膜内分泌细胞变化的免疫组织化学研究

用正常成年雄性Wistar大鼠53只,体重100～150g,分为正常对照组、实验性脾虚组、自然恢复组和四君子汤治疗组。取胃,固定于Bouin液。制成石蜡切片,进行(1)HE染色;(2)免疫组织化学染色,按Sternberger PAP法显示胃泌素细胞(G细胞)、生长抑素细胞(D细胞)和5-HT细胞。根据细胞的免疫反应程度,将细胞分为强阳性、中等阳性和弱阳性三级,每例动物计数三种细胞各1,000个,并计算各级细胞占的百分比;(3)从正常对照组,脾虚组随机选择各5例动物,对D细胞和G细胞进行显微分光光度计的定量测定;(4)由四组动物随机选择各5例,进行G细胞和D细胞密度及G/D细胞比值的测定。本文的观察表明:(1)脾虚组胃粘膜未见明显的组织学变化;(2)内分泌细胞:与对照组相比,脾虚组G细胞和5-HT细胞中,弱阳性细胞增多,表明分泌活动增强;D细胞弱阳性和中等阳性细胞减少,强阳性细胞增多,表明分泌释放减弱,合成增强。与自然恢复组比较,治疗组G细胞和D细胞的分泌活动接近于对照组;5-HT细胞无明显的恢复;(3)显微分光光度计的测定结果与光镜观察一致,脾虚组G细胞胃泌素反应物的含量低于对照组,D细胞内生长抑素反应物的含量高于对照组;(4)脾虚组G细胞密度低于对照组(P<0.01),D细胞密度略高于对照组,G/D细胞比值也低于对照组(P<0.01)。本文结果提示,脾虚证这些内分泌细胞的分泌活动出现异常,可能是导致消化功能紊乱的原因之一。经四君子汤治疗后,内分泌细胞的分泌活动接近于对照组,说明此药对脾虚证有一定的治疗作用。     

新疆药用延胡索资源调查

作者对新疆维吾尔自治区的9个市、县进行了药用延胡索的资源调查,采集植物标本70余份,弄清药用种类主要是3种,即Corydalis glaucescens Regel,C.ledebouriana Kir.et Kar.和C.schanginii(Pall.)Fedtsch.;初步了解了3种药用延胡索植物的分布状况,并对块茎中总生物碱的含量作了分析。     

大蒜病毒检测用抗血清制备的研究

本文报告了从阿城大蒜田间感染病叶片中分离了大蒜病毒,用聚乙二醇沉淀法提取的抗原浓度高于差速离心法.制备的抗血清效价达1024以上.电镜观察粗提纯的病毒粒子,呈线状,长度为516～846nm占46.9%,1142～1525nm占40.6%.     

减压病山羊纤维蛋白原肽链结构与空间构象的研究

本文报道了减压病山羊纤维蛋白原(FG)结构变化及减压病(DCS)气-血界面活性引起凝血反应的作用。雄性山羊15只,加压-减压发生Ⅰ或Ⅱ型DCS,采静脉血用冷乙醇提取血浆FG。经SDS-PG电泳和CM_(22)-色谱分离S-磺酸化FG,发现FG裂解肽段——带4和X、Y峰,(正常对照组无);经HPLC和组分分析发现FG含量和FG氨基酸残基数明显减少(P<0.05),表明FG参入凝血反应其肽链发生裂解。又经圆二色谱分析发现FG α-hilex％明显下降(P<0.01)。DCS山羊FG结构的改变,证实了气-血界面活性作用引起凝血反应。     

人嗜中性白细胞活化蛋白-1/白细胞介素-8合成基因的修正及修正基因在大肠杆菌中的表达

本文采用寡核苷酸介导的定位诱变技术修正了人嗜中性白细胞活化蛋白-1/白细胞介素-8合成基因中出现的合成错误,在该基因编码区的201位插入了原来缺失的G残基,从而使之恢复正确读框。经对修正基因进行DNA全序列测定,表明定位诱变的结果符合设计要求。在此基础上,利用原核高效表达载体pBV220在P_RP_L串联启动子的控制下在大肠杆菌中对该基因进行了表达,并测定了重组人嗜中性白细胞活化蛋白-1/白细胞介素-8的嗜中性白细胞趋化活性。本工作为开展人嗜中性白细胞活化蛋白-1/白细胞介素-8基因工程及蛋白质工程的研究奠定了基础。     

人参多肽基因的酶法体外随机——定位诱变

本文报道了酶法体外随机——定位诱变人参多肽基因的原理和方法。该法把传统的随机诱变和现代的定位诱变融合起来,可灵活控制基因突变的随机性和定位性。我们用双脱氧末端终止法测定了三个突变株的结果证实了该法的合理性和可行性,     

Suppression of the immune response to immunotoxins with anti-CD4 monoclonal antibodies.

Treatment of normal mice with a mAb to CD4 (GK1.5) was explored as a means of inhibiting the antibody response to an immunotoxin. Three days of pretreatment with 200 micrograms of GK1.5 completely abrogated the primary antibody response to a 3-micrograms dose of a mutant diphtheria toxin conjugated to an anti-transferrin receptor antibody. The same dose and schedule of anti-CD4 antibody significantly reduced and delayed, but did not prevent, the anamnestic antitoxin response in animals that had been previously primed to the immunotoxin. Three daily injections of anti-CD4 antibodies followed by weekly doses of immunotoxin resulted in a 3-wk delay in the development of antitoxin antibodies, and the kinetics of the antitoxin response correlated with the kinetics of recovery of CD4+ T cells in the spleen and lymph nodes. The antitoxin response to repeated doses of immunotoxin was completely abrogated when anti-CD4 antibodies were given every 2 wk throughout the course of immunotoxin treatment. Thus, transient depletion of Th cells during treatment can block the immune response to an immunotoxin. There was no evidence of tolerance induction with this regimen.     

Nucleotide sequence and characterization of the sfs1 gene: sfs1 is involved in CRP*-dependent mal gene expression in Escherichia coli.

We have cloned at least 12 different Escherichia coli genes which enable strain MK2001 to use maltose. The genes were designated sfs1 through sfs12 (sugar fermentation stimulation). Previously, one (sfs7) of them was mapped at 65 min on the E. coli chromosome and identified as nlp, which has high homology to repressor protein (Ner) of Mu phage, which contains a putative DNA binding region (Y.-L. Choi, T. Nishida, M. Kawamukai, R. Utsumi, H. Sakai, and T. Komano, J. Bacteriol. 171:5222-5225, 1989). In this study, another gene (sfs1) located at 3.5 min was newly found and analyzed. The nucleotide sequence of sfs1 encoded a protein of 234 amino acids (molecular mass, 26,227 Da) which also has a putative DNA binding domain. Overexpression of the sfs1 gene in MK2001 resulted in a 10-fold increase of amylomaltase, which was still dependent on MalT. These results suggest that Sfs1 could be a new regulatory factor involved in maltose metabolism.     

Synthesis of (+/−)–1′-Aza-carbocyclic-pyrimidine-2′,3′-dideoxynucleoside analogues as potential anti-HIV agents

1′-Aza-carbocyclic-2′, 3′-dideoxyuridine, 3′-deoxythymidine and 2′, 3′-dideoxycytidine were synthesized from 1-aminopyrrolidine intermediate 13 and evaluated as anti-HIV agents in MT-4 cells.